(d) | Details of significant cash transactions such as loans and collection of loans, which occurred in the normal course of business with related parties for the years ended December 31, 2016 and 2017 are as follows: |
(In millions of won) | ||||||||||||||||
Loans(*) | ||||||||||||||||
Associates |
January 1, 2016 | Increase | Decrease | December 31, 2016 | ||||||||||||
New Optics Ltd. |
— | 1,000 | — | 1,000 | ||||||||||||
INVENIA Co., Ltd. |
1,000 | — | 167 | 833 | ||||||||||||
Narenanotech Corporation |
300 | — | — | 300 | ||||||||||||
YAS Co., Ltd. |
1,000 | — | 167 | 833 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
2,300 | 1,000 | 334 | 2,966 | |||||||||||||
|
|
|
|
|
|
|
|
(*) | Loans are presented based on nominal amounts. |
(In millions of won) | ||||||||||||||||
Loans(*1) | ||||||||||||||||
Associates |
January 1, 2017 | Increase | Decrease | December 31, 2017 | ||||||||||||
New Optics Ltd.(*2) |
1,000 | — | 125 | 875 | ||||||||||||
INVENIA Co., Ltd. |
833 | 2,000 | 458 | 2,375 | ||||||||||||
Narenanotech Corporation(*2) |
300 | — | 75 | 225 | ||||||||||||
YAS Co., Ltd. |
833 | — | 458 | 375 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
2,966 | 2,000 | 1,116 | 3,850 | |||||||||||||
|
|
|
|
|
|
|
|
(*1) | Loans are presented based on nominal amounts. |
(*2) Excluded from related parties due to disposal of equity investments during the year ended December 31, 2017.